News Daily News Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks Michael O'Riordan October 07, 2022
News Conference News HFSA 2022 New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented Todd Neale October 07, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Daily News Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use L.A. McKeown October 05, 2022
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022
News Conference News HFSA 2022 Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER Todd Neale October 04, 2022
News Daily News Heart Transplantation After Circulatory Death Gives ‘Encouraging’ Results Yael L. Maxwell September 30, 2022
News Daily News Initiative Lowers Unnecessary Aspirin Use in Warfarin Users Todd Neale September 26, 2022
News Conference News TCT 2022 Pascal TEER Device Performs Well in Patients With Complex Anatomy Yael L. Maxwell September 26, 2022
News Conference News TCT 2022 Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes Todd Neale September 22, 2022
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Conference News TCT 2022 RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP Todd Neale September 18, 2022
News Conference News TCT 2022 Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test Shelley Wood September 18, 2022
News Conference News TCT 2022 Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI Yael L. Maxwell September 18, 2022
News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
News Conference News TCT 2022 As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant Michael O'Riordan September 18, 2022
News Conference News TCT 2022 Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD Shelley Wood September 18, 2022
News Conference News TCT 2022 Dedicated Catheter for Acute PE Shows Promise in IDE Trial L.A. McKeown September 17, 2022